Vident Investment Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-154,716
| Closed | -$17.9M | – | 642 |
|
|
2023
Q2 | $17.9M | Sell |
154,716
-76,249
| -33% | -$8.66M | 0.61% | 27 |
|
|
2023
Q1 | $24.6M | Sell |
230,965
-6,155
| -3% | -$665K | 0.8% | 11 |
|
|
2022
Q4 | $26.3M | Buy |
237,120
+181,059
| +323% | +$18.5M | 0.99% | 7 |
|
|
2022
Q3 | $3.5M | Buy |
56,061
+8,972
| +19% | +$801K | 0.11% | 216 |
|
|
2022
Q2 | $4.29M | Sell |
47,089
-32,534
| -41% | -$2.88M | 0.13% | 192 |
|
|
2022
Q1 | $6.53M | Sell |
79,623
-22,195
| -22% | -$1.75M | 0.17% | 140 |
|
|
2021
Q4 | $7.8M | Buy |
101,818
+13,958
| +16% | +$1.11M | 0.2% | 106 |
|
|
2021
Q3 | $6.6M | Buy |
87,860
+14,994
| +21% | +$1.14M | 0.2% | 100 |
|
|
2021
Q2 | $5.67M | Buy |
72,866
+15,924
| +28% | +$1.18M | 0.17% | 108 |
|
|
2021
Q1 | $4.19M | Sell |
56,942
-16,262
| -22% | -$1.2M | 0.14% | 127 |
|
|
2020
Q4 | $5.71M | Buy |
73,204
+6,761
| +10% | +$517K | 0.23% | 77 |
|
|
2020
Q3 | $5.26M | Buy |
66,443
+19,697
| +42% | +$1.54M | 0.26% | 79 |
|
|
2020
Q2 | $3.45M | Buy |
46,746
+5,404
| +13% | +$407K | 0.18% | 96 |
|
|
2020
Q1 | $3.04M | Sell |
41,342
-23,216
| -36% | -$1.82M | 0.2% | 95 |
|
|
2019
Q4 | $5.6M | Buy |
64,558
+29,343
| +83% | +$2.41M | 0.35% | 45 |
|
|
2019
Q3 | $2.83M | Sell |
35,215
-8,122
| -19% | -$651K | 0.25% | 73 |
|
|
2019
Q2 | $3.47M | Sell |
43,337
-37,586
| -46% | -$2.88M | 0.28% | 70 |
|
|
2019
Q1 | $6.42M | Buy |
80,923
+32,658
| +68% | +$2.44M | 0.35% | 62 |
|
|
2018
Q4 | $3.52M | Sell |
48,265
-10,483
| -18% | -$740K | 0.2% | 96 |
|
|
2018
Q3 | $3.98M | Sell |
58,748
-4,409
| -7% | -$281K | 0.16% | 125 |
|
|
2018
Q2 | $3.66M | Buy |
63,157
+9,976
| +19% | +$563K | 0.14% | 149 |
|
|
2018
Q1 | $2.98M | Buy |
53,181
+8,299
| +18% | +$448K | 0.12% | 245 |
|
|
2017
Q4 | $2.41M | Buy |
44,882
+5,562
| +14% | +$308K | 0.11% | 260 |
|
|
2017
Q3 | $2.4M | Buy |
39,320
+18,020
| +85% | +$1.09M | 0.13% | 249 |
|
|
2017
Q2 | $1.3M | Buy |
21,300
+3,796
| +22% | +$231K | 0.11% | 290 |
|
|
2017
Q1 | $1.06M | Buy |
17,504
+2,416
| +16% | +$147K | 0.11% | 303 |
|
|
2016
Q4 | $848K | Buy |
15,088
+568
| +4% | +$33.2K | 0.1% | 290 |
|
|
2016
Q3 | $865K | Buy |
14,520
+149
| +1% | +$8.71K | 0.11% | 303 |
|
|
2016
Q2 | $790K | Sell |
14,371
-19,894
| -58% | -$1.06M | 0.11% | 296 |
|
|
2016
Q1 | $1.73K | Buy |
34,265
+18,139
| +112% | +$888K | 0.11% | 333 |
|
|
2015
Q4 | $813K | Sell |
16,126
-5,256
| -25% | -$265K | 0.1% | 329 |
|
|
2015
Q3 | $1.01M | Buy |
21,382
+6,113
| +40% | +$325K | 0.14% | 181 |
|
|
2015
Q2 | $829K | Buy |
15,269
+827
| +6% | +$46.4K | 0.11% | 236 |
|
|
2015
Q1 | $792K | Sell |
14,442
-9,549
| -40% | -$541K | 0.16% | 167 |
|
|
2014
Q4 | $1.3M | Buy |
+23,991
| New | +$1.34M | 0.44% | 19 |
|
Other funds holding MRK
Vident Investment Advisory's MRK Position: Q3 2023 in Review
Vident Investment Advisory sold out of Merck (MRK) in Q3 2023, closing a stake of 154,716 shares — an estimated $17.9M sold.
Vident Investment Advisory first reported a position in MRK in Q4 2014 and held it in 35 quarters. The position peaked at $26.3M in Q4 2022. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.
- Vident Investment Advisory reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
- Vident Investment Advisory sold 154,716 Merck shares in Q3 2023, an estimated $17.9M.
- Vident Investment Advisory first reported a position in Merck in Q4 2014 and held it in 35 quarters.
- Vident Investment Advisory's Merck position peaked at $26.3M in Q4 2022.
- 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.
Based on Vident Investment Advisory's 13F filing for Q3 2023.